Search Results - "Hodyrev, D S"
-
1
Methylation of the Promoter Region of the RASSF1A Candidate Tumor Suppressor Gene in Primary Epithelial Tumors
Published in Molecular biology (New York) (01-07-2004)“…The methylation of the promoter CpG island of the RASSF1A tumor suppressor gene in primary tumors of 172 Muscovites with renal cell carcinoma (RCC), breast…”
Get full text
Journal Article -
2
Activation of RHOA transcription in epithelial tumors may be caused by gene amplification and/or demethylation of the promoter region
Published in Molecular biology (New York) (01-10-2006)“…RHOA is a small GTPase involved in morphogenesis, cell adhesion, and cell cycle control. RHOA (3p21.31) is a potential oncogene, causing cell malignant…”
Get full text
Journal Article -
3
Methylation of the Putative Tumor Suppressor Gene RASSF1A in Primary Cervical Tumors
Published in Molecular biology (New York) (01-11-2004)“…Methylation-sensitive restriction endonuclease analysis (MSRA) followed by polymerase chain reaction (PCR) have been used to estimate the methylation level of…”
Get full text
Journal Article -
4
Association of the polymorphisms of the FTO, KCNJ11, SLC30A8 and CDKN2B genes with type 2 diabetes
Published in Molekuliarnaia biologiia (01-01-2015)“…To study the association with diabetes mellitus type 2 we performed anal- ysis of the distribution of frequencies of alleles and genotypes of polymorphic…”
Get more information
Journal Article -
5
Methylation profile of group of miRNA genes in clear cell renal cell carcinoma; involvement in cancer progression
Published in Genetika (01-03-2013)“…MicroRNA regulates gene expression, is involved in many cellular processes, and plays an important role in the development of cancer. The regulation of the…”
Get more information
Journal Article -
6
Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors
Published in Molekuliarnaia biologiia (01-07-2004)“…Methylation of the promoter CpG-islands of the candidate tumor suppressor gene RASSF1A (3p21.31) was studied in primary tumors of kidney, breast and ovary (172…”
Get more information
Journal Article